Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...
WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...
Boone Health is closing its bariatric clinic in Columbia because of lagging demand. "We're working to expand the high-demand ...
Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.
A small percentage have had vision problems, but a direct causal link with the drugs has not been established.
4d
News Medical on MSNVision loss risks in patients using popular GLP-1 medications raise concernsA small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...
A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced ... and tirzepatide (brand names Mounjaro and Zepbound). The paper is one of several in the ...
It addresses the national discussion surrounding the GLP-1 medication shortage (e.g., Ozempic, Wegovy, Saxenda, Mounjaro, Zepbound) and alternative options like compounded formularies from 503A and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results